XML 108 R92.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock Based Compensation - Stock Options, Restricted Stock and Restricted Stock Units Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Number of options      
Balance at beginning of period (shares) 7,650,000 0  
Granted (shares) 0 8,000,000  
Forfeited (shares) (1,270,000) (350,000)  
Vested (shares) 0 0  
Balance at end of period (shares) 6,380,000 7,650,000  
Expected to vest at end of period (shares) 1,480,004    
Exercisable at end of period (shares) 4,899,996    
Weighted-average exercise price      
Balance at beginning of period (USD per share) $ 22.00 $ 0  
Granted (USD per share) 0.00 22.00  
Forfeited (USD per share) 22.00 22.00  
Vested (USD per share) 0 0  
Balance at end of period (USD per share) 22.00 $ 22.00  
Expected to vest at end of period (USD per share) 22.00    
Exercisable at end of period (USD per share) $ 22.00    
Weighted average remaining contractual term (in years) of options outstanding 5 years 6 months 6 years 6 months  
Weighted average remaining contractual term (in years) of options expected to vest 5 years 6 months    
Weighted average remaining contractual term (in years) of options exercisable 5 years 6 months    
Aggregate intrinsic value (in millions)      
Aggregate intrinsic value of options outstanding $ 0.0 $ 22.2
Aggregate intrinsic value of options expected to vest 0.0    
Aggregate intrinsic value of options exercisable $ 0.0    
Restricted stock and restricted stock units      
Number of shares      
Nonvested at beginning of period (shares) 702,899 0  
Granted (shares) 3,053,885 702,899  
Forfeited (shares) (681,615) 0  
Vested (shares) (317,330) 0  
Nonvested at end of period (shares) 2,757,839 702,899  
Weighted-average grant date fair value      
Balance at beginning of period (USD per share) $ 25.95 $ 0  
Distribution (USD per share) 21.37 25.95  
Forfeited (USD per share) 23.03 0  
Vested (USD per share) 25.77 0  
Balance at end of period (USD per share) $ 21.61 $ 25.95  
Weighted average remaining contractual term (in years) 1 year 2 months 12 days 1 year 3 months 18 days  
Aggregate intrinsic value (in millions)      
Aggregate intrinsic value of equity instruments other than options outstanding $ 56.5 $ 17.5
Phantom Units      
Aggregate intrinsic value (in millions)      
Number of equity instruments other than options converted (shares) 205,546